Journal
CURRENT OPINION IN BIOTECHNOLOGY
Volume 12, Issue 5, Pages 450-454Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S0958-1669(00)00244-5
Keywords
-
Ask authors/readers for more resources
Transgenic plants are showing considerable potential for the economic production of proteins, with a few already being marketed. Recent clinical trials of pharmaceuticals produced from transgenic plants are encouraging, with plant glycans showing reassuringly poor immunogenicity. Our increasing understanding of protein targeting and accumulation should further improve the potential of this new technology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
